Pathophysiology of modulation of local glucocorticoid levels by 11beta-hydroxysteroid dehydrogenases.
about
Pseudohyperaldosteronism: pathogenetic mechanismsFrom estrogen-centric to aging and oxidative stress: a revised perspective of the pathogenesis of osteoporosisEnergetic stress: The reciprocal relationship between energy availability and the stress response.11β-hydroxysteroid dehydrogenase 1 specific inhibitor increased dermal collagen content and promotes fibroblast proliferation.Endogenous glucocorticoids decrease skeletal angiogenesis, vascularity, hydration, and strength in aged mice.Effect of 11 beta-hydroxysteroid dehydrogenase-1 inhibition on hepatic glucose metabolism in the conscious dog.Sex-dependent role of glucocorticoids and androgens in the pathophysiology of human obesity.The skin-blanching assay.A pharmacological screening approach for discovery of neuroprotective compounds in ischemic strokeAdrenal and gonadal function in obesity.Transgenic amplification of glucocorticoid action in adipose tissue causes high blood pressure in mice.Discovery of adamantyl heterocyclic ketones as potent 11β-hydroxysteroid dehydrogenase type 1 inhibitorsAdamantyl ethanone pyridyl derivatives: potent and selective inhibitors of human 11β-hydroxysteroid dehydrogenase type 1Glucocorticoid signalling affects pancreatic development through both direct and indirect effects.Rapid non-genomic effects of aldosterone on rodent vascular function.Beclomethasone-induced vasoconstriction in women with major depressive disorder.The hypothalamic-pituitary-adrenal axis and sex hormones in chronic stress and obesity: pathophysiological and clinical aspects.Adamantyl carboxamides and acetamides as potent human 11β-hydroxysteroid dehydrogenase type 1 inhibitors.The hypothalamic-pituitary-adrenal axis activity in obesity and the metabolic syndrome.Antipsychotic drug treatment alters expression of mRNAs encoding lipid metabolism-related proteins.11β-Hydroxysteroid dehydrogenase-1 is a novel regulator of skin homeostasis and a candidate target for promoting tissue repair.Population pharmacokinetic/pharmacodynamic model of subcutaneous adipose 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) activity after oral administration of AMG 221, a selective 11β-HSD1 inhibitor.Interactions between dehydroepiandrosterone and glucocorticoid metabolism in pig kidney: nuclear and microsomal 11beta-hydroxysteroid dehydrogenases.Expression profiles of cortisol-inactivating enzyme, 11β-hydroxysteroid dehydrogenase-2, in human epidermal tumors and its role in keratinocyte proliferation.Dehydroepiandrosterone inhibits the amplification of glucocorticoid action in adipose tissue.Effect of licorice on the reduction of body fat mass in healthy subjects.Regulation of 11beta-HSD genes in human adipose tissue: influence of central obesity and weight loss.Transcriptome profiling and network analysis of genetically hypertensive mice identifies potential pharmacological targets of hypertension.Growth and Stress Axis Responses to Dietary Cholesterol in Nile Tilapia (Oreochromis niloticus) in Brackish Water.Dehydroepiandrosterone Antagonizes Pain Stress-Induced Suppression of Testosterone Production in Male Rats.
P2860
Q28191206-5A7272FA-5E8D-430E-AA83-BF73FD2E2882Q28385120-AAA71B2C-5DBA-46DF-BF2E-8A2D8DAA3DDAQ30252080-63F1433C-83C3-4D7B-9FE1-B8212CE895FBQ31154591-F389E11E-6CE1-4789-A360-4C04B00AAD3EQ33806970-548F480A-4768-4C74-AD95-289EBDB47C57Q33840328-CFF8D0AD-2DAE-494B-A4D8-4E9DC7F8365DQ34014004-EAF7FA22-7B30-452D-90E9-7676FA77AAB6Q34150267-3BC2AC6C-8885-45D4-BD53-11C766E90738Q34853494-FE64DE15-AA7A-4610-A47C-41BE8C956CF7Q35037266-DB5E83E4-FAE7-40CB-B482-BA768159F750Q35108463-DA895B44-041A-40E6-A264-2AAED76DF985Q35207855-C8C97679-77FE-43DD-9774-0D4F260A0DDBQ35231710-84D61D04-E0BF-4512-8901-11F02C4AC2C1Q35828509-CE534702-14D9-4BAC-A83A-70B278917D55Q35850517-C0292029-55C0-4274-B00D-63DDA5078DF7Q35924854-19FB8AF9-35CB-4A22-8881-38A02C0C9A49Q36297743-8CC5F472-4986-46FC-975E-E58953F8356FQ36434907-E3DD5F81-B3A4-4020-91AA-993443C3A589Q36674831-36B2E91C-66DB-437E-82C3-12DAE46A178AQ38347364-75C7CFF0-F432-4747-9584-EEA4A84D32AEQ38530086-B32121D2-E970-4273-9970-87628C81ED98Q39853044-F2762CE3-3919-40C1-BA76-2BCCBA38BFF0Q41968179-959166F2-8991-4FE6-8D9E-DABA1B01A37DQ42520038-4F6498AB-9151-48CD-9C3E-DF1F2A24BA84Q42820080-334B89EC-5029-4C21-9551-F2A328954A59Q44639859-8F326D56-A7ED-4FBC-8905-90CDB1D31C47Q44741685-186F4CB0-8788-446F-827A-C30597482658Q45944027-2CBE1781-79A6-4916-A308-2E06BD5AD4DEQ55050016-339ADEE7-58CF-4F84-A2CC-25D59C77B8C4Q55441105-371F1193-374A-4171-8589-51179427C8D4
P2860
Pathophysiology of modulation of local glucocorticoid levels by 11beta-hydroxysteroid dehydrogenases.
description
2001 nî lūn-bûn
@nan
2001 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Pathophysiology of modulation ...... hydroxysteroid dehydrogenases.
@ast
Pathophysiology of modulation ...... hydroxysteroid dehydrogenases.
@en
Pathophysiology of modulation ...... hydroxysteroid dehydrogenases.
@nl
type
label
Pathophysiology of modulation ...... hydroxysteroid dehydrogenases.
@ast
Pathophysiology of modulation ...... hydroxysteroid dehydrogenases.
@en
Pathophysiology of modulation ...... hydroxysteroid dehydrogenases.
@nl
prefLabel
Pathophysiology of modulation ...... hydroxysteroid dehydrogenases.
@ast
Pathophysiology of modulation ...... hydroxysteroid dehydrogenases.
@en
Pathophysiology of modulation ...... hydroxysteroid dehydrogenases.
@nl
P1476
Pathophysiology of modulation ...... hydroxysteroid dehydrogenases.
@en
P2093
P304
P356
10.1016/S1043-2760(01)00499-4
P577
2001-12-01T00:00:00Z